TG Therapeutics Stock Options

TGTX Stock  USD 42.99  1.10  2.63%   
TG Therapeutics' latest option contracts expiring on May 16th 2025 are carrying combined implied volatility of 0.9 with a put-to-call open interest ratio of 0.51 over 76 outstanding agreements suggesting investors are buying more calls than puts on contracts expiring on May 16th 2025. The total put volume is at 129, with calls trading at the volume of 552. This yields a 0.23 put-to-call volume ratio.

Open Interest Against May 16th 2025 Option Contracts

TG Therapeutics option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in TG Therapeutics' lending market. For example, when TG Therapeutics' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on TG Therapeutics, he or she must hedge the risk by shorting TG Therapeutics stock over its option's life.
The chart above shows TG Therapeutics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. TG Therapeutics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for TG Therapeutics' option, there is no secondary market available for investors to trade.

TG Therapeutics Maximum Pain Price Across 2025-05-16 Option Contracts

Max pain occurs when TG Therapeutics' market makers reach a net positive position across all TG Therapeutics' options at a strike price where option holders stand to lose the most money. By contrast, TG Therapeutics' option sellers may reap the most after selling more options than buying, causing them to expire worthless.

In The Money vs. Out of Money Option Contracts on TG Therapeutics

Analyzing TG Therapeutics' in-the-money options over time can help investors to take a profitable long position in TG Therapeutics regardless of its overall volatility. This is especially true when TG Therapeutics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money TG Therapeutics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with TG Therapeutics' stock while costing only a fraction of its price.

TG Therapeutics In The Money Call Balance

When TG Therapeutics' strike price is surpassing the current stock price, the option contract against TG Therapeutics stock is said to be in the money. When it comes to buying TG Therapeutics' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on TG Therapeutics are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

TGTX Current Options Market Mood

TG Therapeutics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps TGTX Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Unfortunately, most TG Therapeutics' options investors are not very successful. TG Therapeutics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current TGTX contract

Base on the Rule 16, the options market is currently suggesting that TG Therapeutics will have an average daily up or down price movement of about 0.0563% per day over the life of the 2025-05-16 option contract. With TG Therapeutics trading at USD 42.99, that is roughly USD 0.0242. If you think that the market is fully incorporating TG Therapeutics' daily price movement you should consider buying TG Therapeutics options at the current volatility level of 0.9%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Purchasing TG Therapeutics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" TGTX calls. Remember, the seller must deliver TG Therapeutics stock to the call owner when a call is exercised.

TG Therapeutics Option Chain

When TG Therapeutics' strike price is surpassing the current stock price, the option contract against TG Therapeutics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
TG Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on TGTX. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for TGTX. It also shows strike prices and maturity days for a TG Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
TGTX250516C0006000025060.00.7 - 0.90.91Out
Call
TGTX250516C0005500011155.01.2 - 1.41.3Out
Call
TGTX250516C00050000304750.01.15 - 2.32.2Out
Call
TGTX250516C000490007849.02.0 - 3.92.4Out
Call
TGTX250516C0004800046448.02.15 - 2.752.7Out
Call
TGTX250516C000470005347.02.75 - 3.23.0Out
Call
TGTX250516C0004600020946.03.2 - 3.53.2Out
Call
TGTX250516C0004500054245.03.5 - 3.83.65Out
Call
TGTX250516C0004400032744.03.8 - 4.24.02Out
Call
TGTX250516C0004300029143.03.7 - 4.64.36Out
Call
TGTX250516C000420008142.04.8 - 5.15.12Out
Call
TGTX250516C0004100020841.05.2 - 5.65.42In
Call
TGTX250516C00040000107740.05.8 - 6.15.77In
Call
TGTX250516C000390009339.05.7 - 6.66.5In
Call
TGTX250516C0003800082338.06.8 - 7.27.0In
Call
TGTX250516C0003700020637.07.4 - 7.87.89In
Call
TGTX250516C0003600035736.08.1 - 8.68.2In
Call
TGTX250516C00035000336035.08.8 - 9.39.0In
Call
TGTX250516C0003400020434.09.1 - 9.910.01In
Call
TGTX250516C0003300031833.09.0 - 10.610.1In
Call
TGTX250516C0003200013632.011.1 - 11.59.52In
Call
TGTX250516C0003100012531.011.9 - 12.312.2In
Call
TGTX250516C0003000052030.012.2 - 13.013.3In
Call
TGTX250516C000290005429.012.6 - 14.013.2In
Call
TGTX250516C000280003028.014.5 - 14.814.72In
Call
TGTX250516C000270005927.015.2 - 15.814.28In
Call
TGTX250516C0002600014126.016.3 - 16.615.45In
Call
TGTX250516C0002500063925.017.2 - 17.617.41In
Call
TGTX250516C0002400013424.017.4 - 18.518.57In
Call
TGTX250516C0002300032523.019.0 - 19.513.5In
Call
TGTX250516C0002200011222.020.1 - 20.418.8In
Call
TGTX250516C00021000424121.020.2 - 21.421.45In
Call
TGTX250516C000200005620.022.0 - 22.420.5In
Call
TGTX250516C00019000519.022.4 - 23.412.35In
Call
TGTX250516C0001800011618.023.4 - 24.322.11In
Call
TGTX250516C000170001117.023.5 - 25.418.1In
Call
TGTX250516C000160001716.025.5 - 27.119.6In
Call
TGTX250516C0001500026115.026.3 - 27.420.35In
 Put
TGTX250516P00060000060.018.0 - 18.918.0In
 Put
TGTX250516P00055000055.013.5 - 14.513.5In
 Put
TGTX250516P00050000050.09.6 - 10.19.6In
 Put
TGTX250516P00049000049.08.7 - 9.48.7In
 Put
TGTX250516P00048000048.08.1 - 8.58.1In
 Put
TGTX250516P000470001147.07.5 - 7.87.7In
 Put
TGTX250516P00046000246.06.8 - 7.16.7In
 Put
TGTX250516P00045000345.06.1 - 6.56.5In
 Put
TGTX250516P00044000044.05.5 - 6.15.5In
 Put
TGTX250516P00043000543.05.0 - 5.37.0In
 Put
TGTX250516P00042000342.04.4 - 4.95.32Out
 Put
TGTX250516P00041000941.04.0 - 4.24.3Out
 Put
TGTX250516P0004000035940.03.5 - 3.83.6Out
 Put
TGTX250516P000390002439.03.1 - 3.33.3Out
 Put
TGTX250516P000380002338.02.7 - 3.92.75Out
 Put
TGTX250516P000370007537.02.3 - 2.52.35Out
 Put
TGTX250516P000360007136.01.95 - 2.22.21Out
 Put
TGTX250516P0003500057635.01.7 - 1.91.75Out
 Put
TGTX250516P0003400011734.01.4 - 1.651.98Out
 Put
TGTX250516P0003300012133.01.15 - 1.351.15Out
 Put
TGTX250516P0003200035632.00.95 - 1.151.45Out
 Put
TGTX250516P000310002531.00.8 - 0.950.9Out
 Put
TGTX250516P0003000078730.00.65 - 0.80.99Out
 Put
TGTX250516P000290005529.00.5 - 0.650.6Out
 Put
TGTX250516P0002800034628.00.4 - 0.550.65Out
 Put
TGTX250516P000270002127.00.3 - 0.50.57Out
 Put
TGTX250516P000260002026.00.3 - 1.60.43Out
 Put
TGTX250516P0002500061925.00.25 - 0.650.3Out
 Put
TGTX250516P0002400048124.00.05 - 0.950.39Out
 Put
TGTX250516P0002300051523.00.0 - 1.50.35Out
 Put
TGTX250516P0002200059622.00.0 - 0.950.2Out
 Put
TGTX250516P00021000204021.00.0 - 1.151.0Out
 Put
TGTX250516P00020000157020.00.05 - 0.90.2Out
 Put
TGTX250516P0001900040719.00.0 - 1.40.35Out
 Put
TGTX250516P0001800011418.00.0 - 1.250.25Out
 Put
TGTX250516P000170008817.00.0 - 1.40.25Out
 Put
TGTX250516P000160001916.00.0 - 1.41.68Out
 Put
TGTX250516P0001500028115.00.0 - 1.40.1Out

TG Therapeutics Selling And Marketing Expenses Over Time

   Selling And Marketing Expenses   
       Timeline  

TG Therapeutics Market Cap Over Time

   Market Cap   
       Timeline  

TGTX Total Stockholder Equity

Total Stockholder Equity

233.48 Million

At this time, TG Therapeutics' Total Stockholder Equity is fairly stable compared to the past year.

TG Therapeutics Corporate Executives

Elected by the shareholders, the TG Therapeutics' board of directors comprises two types of representatives: TG Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of TGTX. The board's role is to monitor TG Therapeutics' management team and ensure that shareholders' interests are well served. TG Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, TG Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
Sean CPACorporate CFOProfile

Additional Tools for TGTX Stock Analysis

When running TG Therapeutics' price analysis, check to measure TG Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TG Therapeutics is operating at the current time. Most of TG Therapeutics' value examination focuses on studying past and present price action to predict the probability of TG Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TG Therapeutics' price. Additionally, you may evaluate how the addition of TG Therapeutics to your portfolios can decrease your overall portfolio volatility.